World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 52 4070 3754 356 345 242 9309

Emma Morris publications per year

The chart shows the history of publications by Emma Morris between 1970 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Emma Morris published across 56 years, from 1970 to 2025, averaging 6.2 papers a year. Output peaked at 28 publications in 2020. 44 of the 347 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1970 to 2025. Vertical axis: number of publications, 0 to 28. Peak 28 publications in 2020. 1970: 1 publication 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 1 publication 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 1 publication 1997: 0 publications 1998: 1 publication 1999: 1 publication 2000: 5 publications 2001: 3 publications 2002: 4 publications 2003: 10 publications 2004: 13 publications 2005: 23 publications 2006: 1 publication 2007: 8 publications 2008: 12 publications 2009: 9 publications 2010: 17 publications 2011: 15 publications 2012: 15 publications 2013: 12 publications 2014: 13 publications 2015: 9 publications 2016: 11 publications 2017: 8 publications 2018: 6 publications 2019: 14 publications 2020: 28 publications 2021: 22 publications 2022: 21 publications 2023: 19 publications 2024: 17 publications 2025: 27 publications
1970 2025

347 publications in total across all disciplines

View publications per year as a table
Emma Morris: publications per year, 1970 to 2025
Year Publications
1970 1
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 1
1979 0
1980 0
1981 0
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 1
1997 0
1998 1
1999 1
2000 5
2001 3
2002 4
2003 10
2004 13
2005 23
2006 1
2007 8
2008 12
2009 9
2010 17
2011 15
2012 15
2013 12
2014 13
2015 9
2016 11
2017 8
2018 6
2019 14
2020 28
2021 22
2022 21
2023 19
2024 17
2025 27
Total 347
Download as CSV

Emma Morris publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emma Morris sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 242–251 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 242 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160 242
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Emma Morris D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emma Morris sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177 52
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Emma Morris is affiliated with University College London in the United Kingdom. Their research activity is primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. The subfields with a notable focus in their scholarly output include Immunology, Genetics, Oncology, Molecular Biology, and Infectious Diseases.

The main topics of their research encompass Immunodeficiency and Autoimmune Disorders, CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Virus-based gene therapy research, Blood disorders and treatments, Immune Cell Function and Interaction, and COVID-19 Clinical Research Studies.

The following recent papers authored by or involving Emma Morris illustrate their research scope and impact:

  • Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy, 2021, Nature Reviews Immunology

Other frequently cited works coauthored by the scientist, although credited to other primary authors, form relevant context in related research areas:

  • Lentiviral gene therapy for X-linked chronic granulomatous disease, 2020, Nature Medicine
  • Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation, 2022, Nature Immunology
  • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity, 2021, Bone Marrow Transplantation
  • Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome, 2022, Nature Medicine

Emma Morris has collaborated frequently with the following researchers:

  • Siobhan O. Burns
  • Thomas A. Fox
  • Claire Booth
  • Austen Worth
  • Despina Moshous

The most common venues for their publications include:

  • Blood
  • Journal of Clinical Immunology
  • British Journal of Haematology
  • Journal of Allergy and Clinical Immunology
  • Bone Marrow Transplantation

Emma Morris has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom. This distinction reflects an acknowledgment by a professional body within the medical sciences community.

Best Publications

  • Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

    Emma C. Morris;Sattva S. Neelapu;Theodoros Giavridis;Michel Sadelain

  • Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

    Karl S Peggs;Ann Hunter;Rajesh Chopra;Anne Parker

  • Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

    Emma Morris;Kirsty Thomson;Kirsty Thomson;Charles Craddock;Charles Craddock;Prem Mahendra;Prem Mahendra

  • Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

    Karl S. Peggs;Kirsty Thomson;Daniel P. Hart;Johanne Geary

  • Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications.

    Emma C. Morris;Peppy Rebello;Kirsty J. Thomson;Karl S. Peggs

  • Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.

    Shao-An Xue;Liquan Gao;Daniel Hart;Roopinder Gillmore

  • Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

    Unknown

  • The evolution of cellular deficiency in GATA2 mutation

    Rachel E. Dickinson;Paul Milne;Laura Jardine;Sasan Zandi

  • Lentiviral gene therapy for X-linked chronic granulomatous disease.

    Donald B. Kohn;Claire Booth;Elizabeth M. Kang;Sung-Yun Pai

  • Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

    Waseem Qasim;Maurizia Brunetto;Adam J. Gehring;Shao-An Xue

  • Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

    Kirsty J Thomson;Emma C Morris;Adrian Bloor;Gordon Cook

  • T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

    Kirsty J. Thomson;Emma C. Morris;Don Milligan;Anne N. Parker

  • Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity

    C. Roddie;J. P.V. Paul;R. Benjamin;Christopher Gallimore

  • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.

    A. C. Lankester;M. H. Albert;C. Booth;A. R. Gennery

  • Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell–Depleted Allogeneic Transplantation for Hodgkin's Lymphoma

    Karl S. Peggs;Irfan Kayani;Noha Edwards;Panagiotis Kottaridis

  • CD3 limits the efficacy of TCR gene therapy in vivo

    Maryam Ahmadi;Judith W. King;Shao An Xue;Cécile Voisine

  • A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection

    Emma C. Morris;Aristotle Tsallios;Gavin M. Bendle;Shao-an Xue

  • Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment.

    D.V.M Bishop;E Canning;K Elgar;E Morris

  • Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

    Sharyn Thomas;Shao-An Xue;Charles R. M. Bangham;Bent K. Jakobsen

  • Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.

    Karl S. Peggs;Stephen Mackinnon;Catherine D. Williams;Shirley D'Sa

  • Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.

    Gordon Cook;Graeme M. Smith;Keiren Kirkland;Julia Lee

  • Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.

    Kirsty J Thomson;Karl S Peggs;P Smith;James Cavet

Frequent Co-Authors

Hans J. Stauss
Hans J. Stauss University College London
Karl S. Peggs
Karl S. Peggs University College London
David C. Linch
David C. Linch University College London
Siobhan O. Burns
Siobhan O. Burns University College London
Adrian J. Thrasher
Adrian J. Thrasher University College London
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Donald Milligan
Donald Milligan University of Birmingham
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Matthew Collin
Matthew Collin Newcastle University
Mervyn Singer
Mervyn Singer University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees and career pathways can broaden professional opportunities. Many Immunology students consider advancing into healthcare roles such as nurse practitioners, which requires specialized training and certifications.

Transitioning roles within nursing, for example from a Family Nurse Practitioner (FNP) to acute care, is a common career progression. Achieving fnp to acute care certification can open doors to higher-level clinical responsibilities and increase job market competitiveness.

For newcomers to the field, accelerated nursing programs provide a fast-track route to gaining essential qualifications. There are excellent options listed under accelerated nurse practitioner programs that cater to those aiming for rapid advancement in nursing careers while balancing other commitments.

Additionally, career changers without a nursing background can explore tailored curricula through online nursing programs for non nurses. These programs build foundational skills essential for success in healthcare environments.

For prospective students seeking accessible options, the easiest accelerated nursing programs to get into offer flexible paths that remove traditional barriers, making the journey into nursing and related fields more attainable.

Best Scientists Citing Emma Morris

Trending Scientists

Recently Published Articles